Table 1.
Expression pattern of FcγR in different immune cells, its function, and its participation in the ADE of different viruses.
FcγRI | FcγRIIa | FcγRIIb | FcγRIIc | FcγRllla | FcRIIIb | |
---|---|---|---|---|---|---|
(CD64) | (CD32a) | (CD32b) | (CD32c) | (CD16a) | (CD16b) | |
Expressed by human immune cells | Macrophages, Eosinophils, Neutrophils, and Dendritic cells. | Platelets, Macrophages, Neutrophils, and Eosinophils. | Platelets, Dendritic cells, B cells, Mast cells, Neutrophils, and Eosinophils. | Natural Killer cells depend on allele status. | Natural Killer cells, Macrophages, Neutrophils, and Eosinophils. | Macrophages, Neutrophils, and Follicular dendritic cells. |
Binding specificity | IgG1, IgG3, and IgG4. | IgG. | IgG. | IgG. | IgG1 and IgG3. | IgG1 and IgG3. |
Functions | Phagocytosis, respiratory burst activation, and cell activation. | Degranulation, Phagocytosis, and ROI production. | Inhibits the phagocytosis and release of the pro-inflammatory cytokines, Degranulation, platelet activation, and B cell activation. | Phagocytosis and clearing of immune complexes. | Antibody-dependent cell-mediated cytotoxicity (ADCC) initiation, and cytokine release. | Phagocytosis, cytokine, and chemokine release. |
ADE participation of viruses | DENV, Ebola virus, PRRSV, and JEV. | DENV, FIPV, MERS-CoV, SARS-CoV, and WNV SARS-CoV-2. | SARS-CoV-2, DENV, WNV, and PRRSV. | Unknown. | DENV, Ebola virus, HIV, PRRSV, and JEV. | Unknown. |